Our team of experienced drug developers and company builders partner with a new generation of passionate, business-minded scientists to foster each therapeutic program from discovery through clinical trials.
board members
Eric Aguiar
Charles Homcy
Richard Scheller
Ali Satvat
James Momtazee
Neil Kumar
company
Adam Shaywitz
Agis Kydonieus
Ai Li
Alan Ji
Ali Komeyli
Ali Satvat
Alix Alderman
Amy Liu
Amy Rainey
Amy Thompson
Ananth Sridhar
Andrea Orozco
Andreas Betz
Angelos Dovletoglou
Anjali Pandey
Anna Maciag
Anna Wade
Annalisa Nielsen
Anthony Ikeme
April Yang
Asha Rajagopal
Ashley Cooper
Athiwat Hutchaleelaha
Baird Ruch
Becky Dabora
Ben Neel
Benjamin Collman
Bernard Lee
Brett Kuenne
Brian Eater
Brian Metcalf
Brian Stephenson
Bruno Gagnon
Cameron Turtle
Carina Castilla
Carl Dambkowski
Carolina Brekke
Chao Cui
Charles Homcy
Christine Siu
Christopher Brown
Christopher Foo
Chuck Nomides
Chun Jiang
Clayton Beard
Corey Woolfolk
Craig Berman
Curtis Scribner
Dan Gretler
Dan Hoth
Daniel Genov
Daniel Mulreany
Daniela Rogoff
Danny Joh
David Martin
David Nader
David Rintell
David Scott
David Smith
David Turner
Dawn Hill
Dawn Toronto
Debra Jones
Dennis Adair
Donna Cabral-Lilly
Doris Davis
Dwight Nissley
Elizabeth Vadas
Eric Aguiar
Eric Chen
Eric David
Eric Gomez
Ervin Epstein
Evangeline de Guzman
Franco Valle
Frank McCormick
Frank Rockhold
Fred Porter
Fred Reno
Gang Li
Ge Wei
George Koshy
Gerd Kochendoerfer
German Barros
Gillian Saldanha
Glenn Noronha
Hannah Shen
Hans Goldberg
Hao Chen
Hao Wang
Harris Soifer
Hector Rodriguez
Hernan Fuentes
Hiywot Takkele
Holly Condon
Holly Maxfield
Holly Prentice
Hoyoung Huh
Hua Deng
Isabella Graef
partners
BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.
Join Us